Asia Pacific Smart Pills Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 800.00 million |
 Market Size (Forecast Year) |
USD 3,007.09 million |
 CAGR |
% |
| Major Markets Players |
>亚太智能药丸市场，按应用（胶囊内窥镜、药物输送、患者监测）、目标区域（食道、小肠、胃、大肠）、疾病指征（食道疾病、小肠疾病、结肠疾病、其他）、最终用户（医院、诊断中心、研究机构）划分 - 行业趋势和预测到 2030 年。
亚太地区智能药丸市场分析及规模
预计创新药物、医疗设备和先进技术的结合将在预测期内对市场增长发挥重要作用。许多智能药丸正在被分析，以了解其在诊断和治疗多种慢性和急性疾病方面的潜在用途。智能药丸的主要市场参与者主要致力于通过提供现有设备的高级版本来扩大其产品组合。
Data Bridge Market Research 分析了 2023-2030 年预测期内智能药丸市场的增长率。在上述预测期内，智能药丸市场的预期复合年增长率约为 18%。2022 年市场价值为 8 亿美元，到 2030 年将增长至 30.0709 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
亚太智能药丸市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
应用（胶囊内窥镜、药物输送、患者监测）、目标区域（食道、小肠、胃、大肠）、疾病指征（食道疾病、小肠疾病、结肠疾病、其他）、最终用户（医院、诊断中心、研究所） |
|
覆盖国家 |
亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区 |
|
涵盖的市场参与者 |
波士顿科学公司（美国）、通用电气（美国）、美敦力（爱尔兰）、美国微芯片科技公司（美国）、诺华公司（瑞士）、荷兰皇家飞利浦公司（荷兰）、史赛克（美国）、富士胶片控股公司（日本）、INTROMEDIC（韩国）、宾得医疗（印度）、CapsoVision（美国）、Medimetriks Pharmaceuticals, Inc.（美国） |
|
市场机会 |
|
市场定义
Smart pills can be a capsule-sized medical device with cameras, sensors, patches and trackers that help in targeted drug delivery, efficient diagnostic, and patient monitoring. It helps to evaluate the patient's health condition once the patient swallows the pill, which helps in deciding to prescribe medications. In addition, smart pills have been modernised in the field of gastrointestinal diagnosis. The incorporation of innovative drugs, medical devices, and advanced technologies is anticipated to play an important role in further boosting the market during the forecast period.
Asia-Pacific Smart Pills Market Dynamics
Drivers
- Increasing Role in Research and Product Development
Many smart pills are being studied extensively for their potential use in diagnosis and therapeutics of numerous chronic and acute diseases. Market players in developing markets primarily focus on developing innovative products, such as video endoscopy capsules, to take advantage of early market opportunities. The demand for advanced drug delivery systems with several benefits such as optimal use of the active pharmaceutical ingredients, minimized dosage frequency, reduced adverse/side effects, targeted drug delivery, and the safer carrier is pushing the market for smart pills. Market players such as Jinshan Science and Technology (OMOM capsule endoscopy) from China and IntroMedic (MiroCam) from South Korea are examples of such companies are also used in research which in turn boosts the market growth.
- Rising Usage of Smart Pills in Elderly Population
Probable customers of smart pills includes patients with paralysis, immovable patients, and the elderly population. Increased growth in the elderly population is anticipated to boost the demand for advanced medical devices designed to increase the convenience of patients. According to the U.S. Census Bureau, in the next 10 years, there will be a huge increase of approximately 236 million people above 65 globally. This suggests a huge growth opportunity for the market during the forecast period. This factor improves the market growth.
Opportunities
- Utilization in Treating Chronic Patients
People who are suffering from chronic diseases need a particular dose of medication which are likely to target the patient base for smart pills. The companies have provided numerous promotional activities, such as investments, product launches, and acquisitions. For instance, Otsuka (Proteus) launched smart chemotherapy pills in 2019, to improve cancer patients’ outcomes. Also, in 2019, Stanley Black & Decker and Pillo Health launched a pill-dispensing robot companion. Therefore, it boosts the market growth.
- Increasing Demand of Inpatient Pharmacies
由于减少错误、提高效率和速度的需求不断增长，住院药房预计将在智能药丸市场占据主导地位。医院提供术前和术后程序，并拥有大量药房来支持这些流程。据说智能药丸对患者，尤其是严重慢性病患者来说越来越可行，从长远来看可以为医院节省资源。因此，住院来源在市场增长中创造了许多机会。
限制/挑战
- 严格的监管程序
不同机构的严格监管审批阻碍了市场的增长。许多州药房委员会对智能药丸在医疗保健实践中的广泛使用提出了多项要求。智能药丸制造商必须遵守各种法规，因此阻碍了市场的增长。
本智能药丸市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关智能药丸市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
亚太智能药丸市场范围
智能药丸市场根据应用、目标区域、疾病适应症和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
应用
- 胶囊内镜
- 药物输送
- 病人监护
目标区域
- 食管
- 小肠
- 胃
- 大肠
疾病指征
- 食管疾病
- 小肠疾病
- 结肠疾病
- 其他的
最终用户
- 医院
- 诊断中心
- 研究所
智能药丸市场区域分析/见解
对亚太智能药丸市场进行了分析，并根据上述应用、目标区域、疾病指征和最终用户提供了市场规模洞察和趋势。
亚太智能药丸市场报告涵盖的主要国家包括亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太地区其他地区 (APAC)。
日本正在加速智能药丸市场的增长，其中包括强制性医疗保险、技术进步以及胃癌和胃肠道疾病发病率的上升。根据世界癌症研究基金会国际数据，日本在胃癌发病率方面在亚洲国家中排名第三。因此，目标疾病的高发病率以及政府支持的增加将为市场带来巨大的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了亚太地区品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和亚太地区智能药丸市场份额分析
智能药丸市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对智能药丸市场的关注有关。
智能药丸市场的主要参与者包括：
- 波士顿科学公司 (美国)
- 通用电气（美国）
- 美敦力（爱尔兰）
- 微芯片科技公司（美国）
- 诺华公司（瑞士）
- Koninklijke Philips NV（荷兰）
- 史赛克（美国）
- 富士胶片控股株式会社（日本）
- INTROMEDIC（韩国）
- PENTAX 医疗（印度）
- CapsoVision (美国)
- Medimetriks Pharmaceuticals, Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
